FOR IMMEDIATE RELEASE: July 12, 2018 Ken Malone SilcsBio, LLC 410.929.2305 Ken.Malone@silcsbio.com SilcsBio, LLC Announces Issuance of US Patent with Utility in Drug Design Software July 12, 2018 Baltimore, Maryland: SilcsBio, LLC (SilcsBio) announced today the issuance of a US patent covering key elements of SilcsBio’s drug design software. The SilcsBio software is broadly used [...]

SilcsBio has exclusive rights to use U.S. and foreign patents pending by the University of Maryland, Baltimore. Patents include: U.S. Patent Application 13/265,568, titled “Method for binding site identification by molecular dynamics simulation (SILCS: Site Identification by Ligand Competitive Saturation),” published as US 2012/0053067.